These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 15718352

  • 21. In vitro studies on thrombin generation in citrated, r-hirudinized and heparinized whole blood.
    Kaiser B, Fareed J, Walenga JM, Hoppensteadt D, Markwardt F.
    Thromb Res; 1991 Dec 01; 64(5):589-96. PubMed ID: 1808763
    [Abstract] [Full Text] [Related]

  • 22. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T, Szlam F, Vinten-Johansen J, Levy JH, Tanaka KA.
    Blood Coagul Fibrinolysis; 2007 Dec 01; 18(8):761-7. PubMed ID: 17982317
    [Abstract] [Full Text] [Related]

  • 23. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
    Boström SL, Hansson GF, Sarich TC, Wolzt M.
    Thromb Res; 2004 Dec 01; 113(1):85-91. PubMed ID: 15081569
    [Abstract] [Full Text] [Related]

  • 24. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
    Koestenberger M, Gallistl S, Muntean W, Leschnik B, Fritsch P, Cvirn G.
    Thromb Haemost; 2005 Jul 01; 94(1):69-74. PubMed ID: 16113786
    [Abstract] [Full Text] [Related]

  • 25. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM, Mewhort-Buist TA, Berry LR, Chan AK.
    Thromb Haemost; 2009 Jul 01; 102(1):62-8. PubMed ID: 19572069
    [Abstract] [Full Text] [Related]

  • 26. A laboratory method for parallel determination of platelet aggregation and thrombin generation.
    Köstenberger M, Gallistl S, Cvirn G, Muntean W.
    Clin Lab; 2004 Jul 01; 50(1-2):41-8. PubMed ID: 15000219
    [Abstract] [Full Text] [Related]

  • 27. The effect of different anticoagulants on thrombin generation.
    Petros S, Siegemund T, Siegemund A, Engelmann L.
    Blood Coagul Fibrinolysis; 2006 Mar 01; 17(2):131-7. PubMed ID: 16479195
    [Abstract] [Full Text] [Related]

  • 28. Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.
    Cvirn G, Gallistl S, Rehak T, Jürgens G, Muntean W.
    J Thromb Haemost; 2003 Aug 01; 1(8):1785-90. PubMed ID: 12911594
    [Abstract] [Full Text] [Related]

  • 29. Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
    Kottke-Marchant K, Bahit MC, Granger CB, Zoldhelyi P, Ardissino D, Brooks L, Griffin JH, Potthoff RF, Van de Werf F, Califf RM, Topol EJ.
    Eur Heart J; 2002 Aug 01; 23(15):1202-12. PubMed ID: 12127922
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP, Sakariassen KS, Rübsamen K, Thalamas C, Boneu B, Cadroy Y.
    Arterioscler Thromb Vasc Biol; 1999 May 01; 19(5):1348-53. PubMed ID: 10323789
    [Abstract] [Full Text] [Related]

  • 31. Decreased thrombin activity of fibrin clots prepared in cord plasma compared with adult plasma.
    Patel P, Weitz J, Brooker LA, Paes B, Mitchell L, Andrew M.
    Pediatr Res; 1996 May 01; 39(5):826-30. PubMed ID: 8726236
    [Abstract] [Full Text] [Related]

  • 32. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
    Momi S, Nasimi M, Colucci M, Nenci GG, Gresele P.
    Haematologica; 2001 Mar 01; 86(3):297-302. PubMed ID: 11255277
    [Abstract] [Full Text] [Related]

  • 33. Future alternatives to heparin: low-molecular-weight heparin and hirudin.
    Donayre CE, Ouriel K, Rhee RY, Shortell CK.
    J Vasc Surg; 1992 Apr 01; 15(4):675-82. PubMed ID: 1313932
    [Abstract] [Full Text] [Related]

  • 34. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE, Feijge MA, Lancé MD, Hamulyák K, ten Cate H, Heemskerk JW, van Pampus EC.
    Transfusion; 2008 Nov 01; 48(11):2384-94. PubMed ID: 18673348
    [Abstract] [Full Text] [Related]

  • 35. Clinical monitoring of hirudin and direct thrombin inhibitors.
    Nowak G.
    Semin Thromb Hemost; 2001 Oct 01; 27(5):537-41. PubMed ID: 11668425
    [Abstract] [Full Text] [Related]

  • 36. Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbits.
    Kouz J, Czech J, Nicolay U, Dickneite G.
    Haemostasis; 1996 Oct 01; 26(4):179-86. PubMed ID: 8872128
    [Abstract] [Full Text] [Related]

  • 37. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S, Samama MM.
    Blood Coagul Fibrinolysis; 2009 Apr 01; 20(3):207-14. PubMed ID: 19657318
    [Abstract] [Full Text] [Related]

  • 38. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D, Tschopp TB, Hadváry P, Baumgartner HR.
    J Clin Invest; 1994 May 01; 93(5):2073-83. PubMed ID: 8182139
    [Abstract] [Full Text] [Related]

  • 39. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G, Blombäck M, Olsson P, Riesenfeld J.
    Thromb Haemost; 1993 Aug 02; 70(2):289-93. PubMed ID: 8236137
    [Abstract] [Full Text] [Related]

  • 40. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
    Yang XJ, Blajchman MA, Craven S, Smith LM, Anvari N, Ofosu FA.
    Biochem J; 1990 Dec 01; 272(2):399-406. PubMed ID: 2268268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.